US Patent Issued to The Wistar Institute of Anatomy and Biology, Inovio Pharmaceuticals, Geneos Therapeutica on Jan. 20 for "Tumor-specific neoantigens and methods of using the same" (Pennsylvania Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,528,848, issued on Jan. 20, was assigned to The Wistar Institute of Anatomy and Biology, Inovio Pharmaceuticals Inc. and Geneos Therapeutica Inc..

"Tumor-specific neoantigens and methods of using the same" was invented by Elizabeth Kennedy Duperret (Philadelphia), Alfredo Perales Puchalt (Philadelphia), David Weiner (Merion, Pa.) and Niranjan Y. Sardesai (Blue Bell, Pa.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The disclosure relates to methods of manufacturing individualized vaccines that comprise nucleic acid molecules that encode one or more neoantigens specific for antigens that are expressed by a tumor in a subject. Compositions comprising cod...